DecImmune Therapeutics Raises $2.25M
February 26, 2013: DecImmune Therapeutics announced today that it has completed a $2.25 million equity...
February 26, 2013: DecImmune Therapeutics announced today that it has completed a $2.25 million equity...
Nov. 29, 2012 : CardiAQ™ Valve Technologies, Inc., a privately held medical device company developing...
October 27, 2012: Vascular Graft Solutions presents VEST trial at EACTS Live video box presentation:...
September 4, 2012: Laurantis Pharma completes funding round for research program First Human Trial of...
August 27, 2012: CellAegis Devices announces first clinical program to use the Company’s autoRIC™ Device...
July 18, 2012: CellAegis Devices, Inc., announced today that it has received a CE Mark...